CD8A and melanoma: Further, in a study to evaluate the effects of anti-PD-1 therapy in melanoma patients, polyfunctional and persistent, older CD8+T cells were found to drive polyfunctionality of newer monofunctional CD8+ T cells over time (Table 1, study #3) [29].